Skip to main content
Journal cover image

Why Do Patients Undergoing Extremity Prosthetic Reconstruction for Metastatic Disease Get Readmitted?

Publication ,  Journal Article
Lazarides, AL; Flamant, EM; Cullen, MC; Ferlauto, HR; Goltz, DE; Cochrane, NH; Visgauss, JD; Brigman, BE; Eward, WC
Published in: The Journal of arthroplasty
February 2022

Orthopedic oncology patients are particularly susceptible to increased readmission rates and poor surgical outcomes, yet little is known about readmission rates. The goal of this study is to identify factors independently associated with 90-day readmission for patients undergoing oncologic resection and subsequent prosthetic reconstruction for metastatic disease of the hip and knee.This is a retrospective comparative cohort study of all patients treated from 2013 to 2019 at a single tertiary care referral institution who underwent endoprosthetic reconstruction by an orthopedic oncologist for metastatic disease of the extremities. The primary outcome measure was unplanned 90-day readmission.We identified 112 patients undergoing 127 endoprosthetic reconstruction surgeries. Metastatic disease was most commonly from renal (26.8%), lung (23.6%), and breast (13.4%) cancer. The most common type of skeletal reconstruction performed was simple arthroplasty (54%). There were 43 readmissions overall (33.9%). When controlling for confounding factors, body mass index >40, insurance status, peripheral vascular disease, and longer hospital length of stay were independently associated with risk of readmission (P ≤ .05).Readmission rates for endoprosthetic reconstructions for metastatic disease are high. Although predicting readmission remains challenging, risk stratification presents a viable option for helping minimize unplanned readmissions.III.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

The Journal of arthroplasty

DOI

EISSN

1532-8406

ISSN

0883-5403

Publication Date

February 2022

Volume

37

Issue

2

Start / End Page

232 / 237

Related Subject Headings

  • Risk Factors
  • Retrospective Studies
  • Postoperative Complications
  • Patient Readmission
  • Orthopedics
  • Neoplasms
  • Lower Extremity
  • Humans
  • Cohort Studies
  • 4003 Biomedical engineering
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lazarides, A. L., Flamant, E. M., Cullen, M. C., Ferlauto, H. R., Goltz, D. E., Cochrane, N. H., … Eward, W. C. (2022). Why Do Patients Undergoing Extremity Prosthetic Reconstruction for Metastatic Disease Get Readmitted? The Journal of Arthroplasty, 37(2), 232–237. https://doi.org/10.1016/j.arth.2021.10.019
Lazarides, Alexander L., Etienne M. Flamant, Mark C. Cullen, Harrison R. Ferlauto, Daniel E. Goltz, Niall H. Cochrane, Julia D. Visgauss, Brian E. Brigman, and William C. Eward. “Why Do Patients Undergoing Extremity Prosthetic Reconstruction for Metastatic Disease Get Readmitted?The Journal of Arthroplasty 37, no. 2 (February 2022): 232–37. https://doi.org/10.1016/j.arth.2021.10.019.
Lazarides AL, Flamant EM, Cullen MC, Ferlauto HR, Goltz DE, Cochrane NH, et al. Why Do Patients Undergoing Extremity Prosthetic Reconstruction for Metastatic Disease Get Readmitted? The Journal of arthroplasty. 2022 Feb;37(2):232–7.
Lazarides, Alexander L., et al. “Why Do Patients Undergoing Extremity Prosthetic Reconstruction for Metastatic Disease Get Readmitted?The Journal of Arthroplasty, vol. 37, no. 2, Feb. 2022, pp. 232–37. Epmc, doi:10.1016/j.arth.2021.10.019.
Lazarides AL, Flamant EM, Cullen MC, Ferlauto HR, Goltz DE, Cochrane NH, Visgauss JD, Brigman BE, Eward WC. Why Do Patients Undergoing Extremity Prosthetic Reconstruction for Metastatic Disease Get Readmitted? The Journal of arthroplasty. 2022 Feb;37(2):232–237.
Journal cover image

Published In

The Journal of arthroplasty

DOI

EISSN

1532-8406

ISSN

0883-5403

Publication Date

February 2022

Volume

37

Issue

2

Start / End Page

232 / 237

Related Subject Headings

  • Risk Factors
  • Retrospective Studies
  • Postoperative Complications
  • Patient Readmission
  • Orthopedics
  • Neoplasms
  • Lower Extremity
  • Humans
  • Cohort Studies
  • 4003 Biomedical engineering